| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |